Repligen officials say the trio of acquisitions (proposed ARTeSYN, completed EMT & NMS) moves its current Systems offering beyond hollow fiber to also include downstream chromatography systems, flat ...
WALTHAM, Mass., July 31, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced Novasign and Repligen have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results